Zinzani P, Alinari L, Tani M, Fina M, Pileri S, Baccarani M. Preliminary observations of a phase II study of reduced-dose alemtuzumab treatment in patients with pretreated T-cell lymphoma. Haematologica [Internet]. 2005May1 [cited 2026Nov.7];90(5):702-3. Available from: https://haematologica.org/article/view/3537